Six months MDT for paucibacillary leprosy: nerve damage and relapse.
D004359:Drug Therapy, Combination; D005002:Ethiopia; D006801:Humans; D007194:India; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy* / Q000473:pathology; D010525:Peripheral Nerves / Q000473:pathology; D012008:Recurrence; D013997:Time Factors
D007917:Leprostatic Agents